SSE launches new Center for Resilient Health
The Center for Resilient Health brings together researchers across SSE’s world-leading academic departments with affiliated scholars from other universities.
“We conduct research and provide education on health and social care innovations, improved healthcare systems, inclusive access to quality healthcare and a sustainable life sciences sector. Our vision is to help driving positive change in healthcare for the betterment of communities worldwide,” says Karl Wennberg, Professor at the Center for Resilient Health.
The new Center for Resilient Health at SSE was established in collaboration with AstraZeneca.
“At AstraZeneca, we are extremely happy and proud to initiate this long-term collaboration with the House of Governance and Public Policy at the Stockholm School of Economics and form a Center for Resilient Health,” says Anna-Lena Engwall, Country President Nordic at AstraZeneca.
“There is a lot of pressure on the Swedish healthcare services today due to demographic challenges, limited resources and staff shortages. At the same time, scientific developments are moving forward rapidly with innovative treatments that will change healthcare fundamentally. This will require new ways of working, with new structures and collaborations, as well as a greater focus on prevention. Supported by insights and actions, I’m convinced that the House of Governance and Public Policy can build knowledge and networks, thereby contributing to the solutions to many of these challenges. At AstraZeneca, we look forward to contributing in any way we can,” says Engwall.
For more information, please contact:
Karl Wennberg, Professor at the Center for Resilient Health at the Stockholm School of Economics
Phone: +46 70-510 53 66
Read more about the Center for Resilient Health:
About Stockholm School of Economics
The Stockholm School of Economics is rated as a top business school in the Nordic and Baltic countries and enjoys a strong international reputation. World-class research forms the foundation of our educational offering, which includes bachelor, master, PhD, MBA, and Executive Education programs. Our programs are developed in close cooperation with the business and research communities, providing graduates substantial potential to attain leading positions in companies and other organizations.
The school is accredited by EQUIS, certifying that all of its principal activities – teaching as well as research – maintain the highest international standards. The Stockholm School of Economics is also the only Swedish member institution of CEMS and PIM, which are collaborations between top business schools worldwide, contributing to the level of quality for which our school is known.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.